ProSci

SARS-CoV-2 (COVID-19) Nucleocapsid Antibody [3869]

Product Code:
 
PSI-35-723
Product Group:
 
Primary Antibodies
Supplier:
 
ProSci
Host Type:
 
Mouse
Antibody Isotype:
 
Mouse IgG1
Antibody Clonality:
 
Monoclonal
Antibody Clone:
 
3869
Regulatory Status:
 
RUO
Target Species:
 
Virus
Applications:
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Immunofluorescence (IF)
Shipping:
 
blue ice or RT
Storage:
 
Coronavirus Nucleocapsid Antibody can be stored at -20˚C, stable for one year.
 

No additional charges, what you see is what you pay! *

CodeSizePrice
PSI-35-723-0.1mg0.1mg£638.00
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 14-21 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • Show All

Further Information

Additional Names:
Coronavirus Nucleocapsid, SARS
Application Note:
Suggested starting ranges are 1:10-1:50 for IFA and 1:20-1:200 for ELISA. BEST ELISA pairs (capture-conjugate): clones 3869-3868 / 3869-3866
Buffer:
Coronavirus Nucleocapsid Antibody is in a phosphate saline buffer (0.01M, pH 7.2) containing 0.1% sodium azide preservative. No stabilizing proteins have been added.
Concentration:
batch dependent
Conjugate:
Unconjugated
DISCLAIMER:
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Physical State:
Liquid
Purification:
Coronavirus Nucleocapsid Antibody is purified from ascites fluid or culture medium by protein A chromoatography or sequential differential precipitations.
Research Area:
Infectious Disease, COVID-19
SPECIFICITY:
Specific for the nucleocapsid of Covid-19 virus. Cross reacts with SARS. These antibodies are non-reactive with: Influenza A, Influenza B, Adenovirus and MERS.
User NOte:
Optimal dilutions for each application to be determined by the researcher.